Video abstract.mp4 (61.11 MB)

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study

Download (61.11 MB)
media
posted on 08.07.2020 by Robert T. Naismith, Annette Wundes, Tjalf Ziemssen, Elzbieta Jasinska, Mark S. Freedman, Anthony J. Lembo, Krzysztof Selmaj, Ilda Bidollari, Hailu Chen, Jerome Hanna, Richard Leigh-Pemberton, Maria Lopez-Bresnahan, Jennifer Lyons, Catherine Miller, David Rezendes, Jerry S. Wolinsky, on behalf of the EVOLVE-MS-2 study group

The above video abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.


History

Exports